Prophylactic steroids for pediatric open heart surgery

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Robertson Mal, Suzi ^a   Afrane, B ^b   El Barbary, M ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NONE

Author keywords

Adolescent; Adrenal cortex hormones *therapeutic use ; Cardiac surgical procedures *adverse effects ; Infant, newborn; Injections, intravenous; Intensive care units, pediatric; Length of stay

Indexed keywords

ANTIINFLAMMATORY AGENT; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MEPREDNISONE; MINERALOCORTICOID; PLACEBO; PREDNISONE;

CARDIOPULMONARY BYPASS; CHILD CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEMODYNAMICS; HUMAN; IMMUNE RESPONSE; INFECTION; MEDICAL ASSESSMENT; MEDICAL LITERATURE; META ANALYSIS; MORBIDITY; MORTALITY; MYOCARDITIS; NEWBORN INTENSIVE CARE; OPEN HEART SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEROID THERAPY; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT OUTCOME;

EID: 44949239719     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005550.pub2     Document Type: Review

References (37)

1. Bronicki 2000 {published data only} *Bronicki R, Backer C, Baden H, Mavroudis C, Crawford S, Green T. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Annals of Thoracic Surgery 2000;69:1490-5.
2. Checchia PA, Backer CL, Bronicki RA, Baden HP, Crawford SE, GreenTP, et al.Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Critical Care Medicine 2003;31(6):1742-5.
3. Lindberg 2003 {published data only} Lindberg L, Forsell C, Jogi P, Olsson K. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after pediatric cardiac surgery. British Journal of Anaesthesia 2003;90(3):728-32.
4. Schroeder 2003 {published data only} Schroeder V, Pearl JM, Schwartz SM, Shanley TP, Manning PB, Nelson DP. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression. Circulation 2003;107:2823-8.
5. Varan 2002 {published data only} Varan B, Tokel K, Mercan S, Donmez A, Aslamaci S. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: High dose versus low dose. Pediatric Cardiology 2002;23:437-41.
6. Checchia 2005 Checchia PA, Bronicki RA, Costello JM, Nelson DP. Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers. Pediatric Critical Care 2005;6:441-4.
7. Chew 2001 Chew M, Brandslund I, Brix-Christensen V, Ravn H, Hjortdal V, Pedersen J et.al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology 2001;94:745-53.
8. Duval 1999 Duval E, Kavelaars A, Veenhuizen L, van Vught AJ, van de Wal HJ, Heijnen CJ. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. European Journal of Pediatrics 1999;158:387-93.
9. Eguchi 1969 Eguchi S, Aoki E, Hoshino K, Terashima M, Matsuzawa H. Massive administration of corticosteroids during open heart surgery - experimental and clinical studies. Japanese Journal of Thoracic Surgery 1969;22:262-9.
10. Gessler 2005 Gessler P, Hohl V, Carrel T, Pfenninger J, Schmid ER, Baenziger O, et al.Administration of steroids in pediatric cardiac surgery: Impact on clinical outcome and systemic inflammatory response. Pediatric Cardiology 2005;26:595-600.
11. Malagon 2005a Malagon I, Onkenhout W, Klok M, Linhorst L, van de Poel P, Bovill J, et al.Dexamethasone reduces gut permeability in pediatric cardiac surgery. Journal of Thoracic & Cardiovascular Surgery 2005;130(2):265-71.
12. Malagon 2005b Malagon I, Hogenbirk K, van P, Hazekamp M, Bovill J. Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery. Intensive Care Medicine 2005;31:1420-6.
13. Mott 2001 Mott A, Fraser C, Kusnoor A, Giesecke N, Ruel G, Drescher K, et al.The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. Journal of the American College of Cardiology 2001;37(6):1700-6.
14. Shore 2001 Shore S, Nelson D, Pearl J, Manning P, Wong H, Shanley TP, et.al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. American Journal of Cardiology 2001;88(5):591-4.
15. Toledo-Pereyra 1980 Toledo-Pereyra L, Lin C, Kundler H, Replogle R. Steroids in heart surgery: a clinical double-blind and randomized study. American Surgeon 1980;46:155-60.
16. Wilson 1994 Wilson NJ, Weber SA, Peterson MWH, Sandor GGS, Tipple M, LeBlanc J. Double-blinded placebo controlled trial of corticosteroids in children with postpericardiotomy syndrome. Pediatric Cardiology 1994;15:62-5.
17. Huber 1992 Huber A, Schranz D, Keller M, Grimm W, Hafner G, Oelert H. Effect of preoperative dexamethasone on inflammatory reaction after cardiac surgery in children. A randomized placebo controlled study [Entzundungsreaktion nach kardiochirurgischer korrektur angeborener herzfehler - einfluss einer randomisiert, plazebo-kontrollierten, praoperativen dexamethasonbehandlung]. Intensivmedizin und Notfallmedizin 1992;29(6):298-303.
18. Budettte 2004 Burdette SD, Parilo M, Kaplan L. Systemic Inflammatory Response Syndrome. http://www.emedicine.com/med/topic2227.htmdate accessed: 14 July, 2004.
19. Casey 1993 Casey LC. Roles of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Annals of Thoracic Surgery 1993;56(5 Suppl):S92-S96.
20. Clapp 1998 Clapp SK. Postoperative inflammatory syndromes. In: GarsonA, BrickerJT, FisherDJ, NeishSR editor(s). The Science and Practice of Pediatric Cardiology. 2nd Edition. Williams and Wilkins, 1998:1817-21.
21. Drusin 1965 Drusin LM, Engle MA, Hagstrom WC, Schwartz MS. The postpericardiotomy syndrome: a six-year epidemiologic study. New England Journal of Medicine 1965;272:597-602.
22. El Barbary 2002 El Barbary M, Khabar KS. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass. Critical Care Medicine 2002;30(8): 1712-6.
23. Friedrich 2003 Friedrich B, Schmidt R, Reiss I, Gunther A, Seeger W, Muller M, at al. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children. Critical Care Medicine 2003;31 (1):284-90.
24. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
25. Johnson 1999 Johnson MR. Low systemic vascular resistance after cardiopulmonary bypass: Are we any closer to understanding the enigma?. Critical Care Medicine 1999;27(6):1048-50.
26. Kimmel 1991 Kimmel SC, van de Stouwe MJ, Levin RI, Weissmann G, Cronstein BN. A final common pathway for antiinflammatory agents: ihibition of leukocyte-endothelial interactions. Transactions of the Association of American Physicians 1991;104:113-24.
27. Lequier 2000 Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, et al.Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 2000;117(6):1706-12.
28. Maharaj 2004 Maharaj C, Laffey JG. New strategies to control the inflammatory response in cardiac surgery. Current Opinion in Anaesthesiology 2004;17(1):35-48.
29. Mayumi 1997 Mayumi H, Zhang QW, Nakashima A, Matsuda M, Kohno H, Kawachi Y, et al.Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Annals of Thoracic Surgery 1997;63:129-37.
30. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
31. Morton 1976 Morton JR, Hiebert CA, Lutes, White RL. Effect of methylprednisolone on myocardial preservation during coronary artery surgery. American Journal of Surgery 1976;131:419-22.
32. Niazi 1979 Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 1979;76:262-8.
33. Schultz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
34. Seghaye 1993 Seghaye MC, Engelhardt W, Grabitz RG, Faymonville ME, Hornchen H, Messmer BJ, Von Bernuth G. Multiple system organ failure after open heart surgery in infants and children. Thoracic & Cardiovascular Surgeon 1993;41(1):49-53.
35. Tarnok 2001 Tarnok A, Schneider P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock 2001;16(Suppl 1):24-32.
36. Van den Berghe 2001 Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al.Intensive insulin therapy in critically ill patients. New England Journal of Medicine 2001;345(19):1359-1367.
37. Wakabayashi 1993 Wakabayashi G, Ueda M, Shimazu M, et al.Pro and anti-inflammatory cytokines production from human moncytes -The effect of methylprednisolone. Dig Organ Immunol 1993;28:13-7.